24 November 2010
Commenting on Professor Harrington’s Independent Review of the Work Capability Assessment, Duleep Allirajah, Policy Manager at Macmillan Cancer Support, said:
‘We welcome Professor Harrington’s Independent Review of the Work Capability Assessment, especially his plans to look at improving the experiences of people with fluctuating conditions like cancer.
‘However, we are disappointed that the review failed to address the inequity in access to benefits. The current system exempts people who are terminally ill or receiving chemotherapy intravenously from having to go for medical assessments but not people receiving radiotherapy or oral chemotherapy.
‘Receiving oral chemotherapy or radiotherapy is also stressful and debilitating. Nobody undergoing cancer treatment, regardless of the type, should have to jump through hoops to get the support they need.
‘We strongly urge Professor Harrington to look at this matter in future in his role as independent reviewer.'
For more information please contact:
Rebecca Openshaw | Media & PR Officer | Macmillan Cancer Support
89 Albert Embankment
Tel: 020 7840 4699
Out of hours: 07801 307068